What does CENTRUMAPOTHEEK BEERSE do?

CENTRUMAPOTHEEK BEERSE is a pharmacy in Beerse. Private Limited, started on 28 June 1983, 1 establishment.

What is the address of CENTRUMAPOTHEEK BEERSE?

The registered office of CENTRUMAPOTHEEK BEERSE is located at Kerkplein 6 box 1, 2340 Beerse.

Is CENTRUMAPOTHEEK BEERSE still active?

Yes. According to the CBE (30 October 2026) CENTRUMAPOTHEEK BEERSE is active, legal situation “Normale toestand”, started on 28 June 1983.

Is CENTRUMAPOTHEEK BEERSE registered on Peppol?

Yes, CENTRUMAPOTHEEK BEERSE is registered on the Peppol network with ID 0208:0424367971.

What is the enterprise number of CENTRUMAPOTHEEK BEERSE?

The enterprise number of CENTRUMAPOTHEEK BEERSE is BE0424367971.

When was CENTRUMAPOTHEEK BEERSE founded?

CENTRUMAPOTHEEK BEERSE was founded on 28 June 1983.

Who are the directors of CENTRUMAPOTHEEK BEERSE?

According to the 2025 annual accounts, the directors of CENTRUMAPOTHEEK BEERSE are: Jeroen Desmidt.

Is CENTRUMAPOTHEEK BEERSE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 1983; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CENTRUMAPOTHEEK BEERSE make in 2025?

CENTRUMAPOTHEEK BEERSE posted a profit after taxes of € 47,166 in financial year 2025.

What is the revenue of CENTRUMAPOTHEEK BEERSE?

As a small company, CENTRUMAPOTHEEK BEERSE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 380,682.

How much does an employee at CENTRUMAPOTHEEK BEERSE earn?

The average wage cost per full-time employee at CENTRUMAPOTHEEK BEERSE was € 75,400 in 2025: staff costs of € 143,228 for 1.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does CENTRUMAPOTHEEK BEERSE have?

According to the 2025 annual accounts, CENTRUMAPOTHEEK BEERSE has 1.9 full-time equivalents (FTE).

CENTRUMAPOTHEEK BEERSE (Private Limited) - Beerse

Dossier CENTRUMAPOTHEEK BEERSE, printed on 30 October 2026 from databakkes.be/en/0424367971/centrumapotheek-beerse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 31 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

CENTRUMAPOTHEEK BEERSE from Beerse, company number BE0424367971, closed financial year 2025 with a result of € 47,166 after tax. For that financial year CENTRUMAPOTHEEK BEERSE recorded a gross margin of € 380,682 and equity of € 470,358. Compared with financial year 2024, the result moved from € 25,758 to € 47,166. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 470,358

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 47,166

▲ 83% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,959

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 13,901 paid out

29 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

1.9

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 143,228

▼ 7% vs 2024

€ 75,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 311

▼ 91% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 290,887

▼ 9% vs 2024

€ 29,441 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 47,784

▼ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 29,015

▼ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 313,536 Gross margin 2022: € 313,536 First fiscal year in the series	€ 353,600 Gross margin 2023: € 353,600 ▲ 13% vs 2022 (€ 313,536) Favourable step	€ 377,525 Gross margin 2024: € 377,525 ▲ 7% vs 2023 (€ 353,600) Favourable step	€ 380,682 Gross margin 2025: € 380,682 ▲ 1% vs 2024 (€ 377,525) Favourable step	▲ 1%
Profit after taxes	€ 75,599 Profit after taxes 2022: € 75,599 First fiscal year in the series	€ 80,382 Profit after taxes 2023: € 80,382 ▲ 6% vs 2022 (€ 75,599) Favourable step	€ 25,758 Profit after taxes 2024: € 25,758 ▼ 68% vs 2023 (€ 80,382) Unfavourable step	€ 47,166 Profit after taxes 2025: € 47,166 ▲ 83% vs 2024 (€ 25,758) Favourable step	▲ 83%
Equity	€ 383,516 Equity 2022: € 383,516 First fiscal year in the series	€ 440,925 Equity 2023: € 440,925 ▲ 15% vs 2022 (€ 383,516) Favourable step	€ 437,093 Equity 2024: € 437,093 ▼ 1% vs 2023 (€ 440,925) Unfavourable step	€ 470,358 Equity 2025: € 470,358 ▲ 8% vs 2024 (€ 437,093) Favourable step	▲ 8%
Total debts	€ 1,532,522 Total debts 2022: € 1,532,522 First fiscal year in the series	€ 1,422,595 Total debts 2023: € 1,422,595 ▼ 7% vs 2022 (€ 1,532,522) Favourable step	€ 1,285,732 Total debts 2024: € 1,285,732 ▼ 10% vs 2023 (€ 1,422,595) Favourable step	€ 1,155,904 Total debts 2025: € 1,155,904 ▼ 10% vs 2024 (€ 1,285,732) Favourable step	▼ 10%
Cash	€ 35,777 Cash 2022: € 35,777 First fiscal year in the series	€ 49,135 Cash 2023: € 49,135 ▲ 37% vs 2022 (€ 35,777) Favourable step	€ 44,867 Cash 2024: € 44,867 ▼ 9% vs 2023 (€ 49,135) Unfavourable step	€ 52,959 Cash 2025: € 52,959 ▲ 18% vs 2024 (€ 44,867) Favourable step	▲ 18%
Land & buildings	€ 1,491,381 Land & buildings 2022: € 1,491,381 First fiscal year in the series	€ 1,405,508 Land & buildings 2023: € 1,405,508 ▼ 6% vs 2022 (€ 1,491,381) Unchanged	€ 1,318,558 Land & buildings 2024: € 1,318,558 ▼ 6% vs 2023 (€ 1,405,508) Unchanged	€ 1,231,608 Land & buildings 2025: € 1,231,608 ▼ 7% vs 2024 (€ 1,318,558) Unchanged	▼ 7%
Retained profit	€ 364,924 Retained profit 2022: € 364,924 First fiscal year in the series	€ 422,333 Retained profit 2023: € 422,333 ▲ 16% vs 2022 (€ 364,924) Favourable step	€ 418,501 Retained profit 2024: € 418,501 ▼ 1% vs 2023 (€ 422,333) Unfavourable step	€ 451,766 Retained profit 2025: € 451,766 ▲ 8% vs 2024 (€ 418,501) Favourable step	▲ 8%
Dividend	€ 3,013 Dividend 2022: € 3,013 First fiscal year in the series	€ 22,973 Dividend 2023: € 22,973 ▲ € 19,961 vs 2022 (€ 3,013) Unchanged	€ 29,590 Dividend 2024: € 29,590 ▲ 29% vs 2023 (€ 22,973) Unchanged	€ 13,901 Dividend 2025: € 13,901 ▼ 53% vs 2024 (€ 29,590) Unchanged	▼ 53%
Bank debt	€ 373,440 Bank debt 2022: € 373,440 First fiscal year in the series	€ 346,838 Bank debt 2023: € 346,838 ▼ 7% vs 2022 (€ 373,440) Favourable step	€ 319,349 Bank debt 2024: € 319,349 ▼ 8% vs 2023 (€ 346,838) Favourable step	€ 290,887 Bank debt 2025: € 290,887 ▼ 9% vs 2024 (€ 319,349) Favourable step	▼ 9%
Balance sheet total	€ 1,916,038 Balance sheet total 2022: € 1,916,038 First fiscal year in the series	€ 1,863,520 Balance sheet total 2023: € 1,863,520 ▼ 3% vs 2022 (€ 1,916,038) Unchanged	€ 1,722,825 Balance sheet total 2024: € 1,722,825 ▼ 8% vs 2023 (€ 1,863,520) Unchanged	€ 1,626,262 Balance sheet total 2025: € 1,626,262 ▼ 6% vs 2024 (€ 1,722,825) Unchanged	▼ 6%
Employees (FTE)	1.9 Employees (FTE) 2022: 1.9 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 ▼ 0.1 vs 2022 (1.9) Unchanged	2.2 Employees (FTE) 2024: 2.2 ▲ 0.4 vs 2023 (1.8) Unchanged	1.9 Employees (FTE) 2025: 1.9 ▼ 0.3 vs 2024 (2.2) Unchanged	▼ 0.3

Key figures of CENTRUMAPOTHEEK BEERSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CENTRUMAPOTHEEK BEERSE?

What happened at CENTRUMAPOTHEEK BEERSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 47,166 (▲ 83% vs 2024). Source: NBB ↗
Jul 1, 1983 New establishment in Beerse. KBO
Jun 28, 1983 Start of the company according to the CBE. KBO

In short

From € 75,599 profit in 2022 to € 47,166 profit in 2025.

Paid € 55,296 in corporate taxes since 2022.

Best year ever: 2023, with € 80,382 profit.

On average € 200,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Jeroen Desmidt

CENTRUMAPOTHEEK BEERSE

Centrumapotheek Vosselaar

Behind CENTRUMAPOTHEEK BEERSE is Jeroen Desmidt. Jeroen Desmidt is also behind Centrumapotheek Vosselaar.

Directors

According to the 2025 annual accounts

Jeroen Desmidt

Bestuurder

Also active at: Centrumapotheek Vosselaar

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkplein 6 box 1

2340 Beerse

2.022.673.395

Kerkplein 6 box bus 1

2340 Beerse

Active since 1 July 1983

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0424.367.971

VAT number

BE 0424.367.971

Registered office

Kerkplein 6 bus 1, 2340 Beerse

Names & denominations

CENTRUMAPOTHEEK BEERSE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 June 1983

Peppol

Active · Active since 7 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

CENTRUMAPOTHEEK BEERSE

Warning lights

Financials

What happened to CENTRUMAPOTHEEK BEERSE?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions